Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells. - Wikidata - wikimedia - TriplyDB

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

http://www.wikidata.org/entity/Q33564264

about

Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy TRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroids Trail resistance induces epithelial-mesenchymal transition and enhances invasiveness by suppressing PTEN via miR-221 in breast cancer.TNFα cooperates with IFN-γ to repress Bcl-xL expression to sensitize metastatic colon carcinoma cells to TRAIL-mediated apoptosis.Sub-lethal irradiation of human colorectal tumor cells imparts enhanced and sustained susceptibility to multiple death receptor signaling pathways.The TRAIL of oncogenes to apoptosis.Breast cancer genes PSMC3IP and EPSTI1 play a role in apoptosis regulation.High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde Verticillin A overcomes apoptosis resistance in human colon carcinoma through DNA methylation-dependent upregulation of BNIP3.Enhancing apoptosis in TRAIL-resistant cancer cells using fundamental response rules Mathematical Modelling of Molecular Pathways Enabling Tumour Cell Invasion and Migration.The role of Cullin3-mediated ubiquitination of the catalytic subunit of PP2A in TRAIL signaling Geldanamycin induces apoptosis in human gastric carcinomas by affecting multiple oncogenic kinases that have synergic effects with TNF-related apoptosis-inducing ligand.Smad7 protein induces interferon regulatory factor 1-dependent transcriptional activation of caspase 8 to restore tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy Therapeutic applications of TRAIL receptor agonists in cancer and beyond.Regulation of the Src-PP2A interaction in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family.Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer.Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2.Cellular Prion Protein (PrPc) and Hypoxia: True to Each Other in Good Times and in Bad, in Sickness, and in Health Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells.Sensitization of hepatocellular carcinoma cells to Apo2L/TRAIL by a novel Akt/NF-κB signalling inhibitor.The DeISGylase USP18 limits TRAIL-induced apoptosis through the regulation of TRAIL levels: Cellular levels of TRAIL influences responsiveness to TRAIL-induced apoptosis.Ethanol promotes cytotoxic effects of tumor necrosis factor-related apoptosis-inducing ligand through induction of reactive oxygen species in prostate cancer cells.Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration.Mesenchymal stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine.The intrinsically kinase-inactive EPHB6 receptor predisposes cancer cells to DR5-induced apoptosis by promoting mitochondrial fragmentation.N-terminal gelsolin fragment potentiates TRAIL mediated death in resistant hepatoma cells Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy.Guggulsterone induces heme oxygenase-1 expression through activation of Nrf2 in human mammary epithelial cells: PTEN as a putative target.Developing TRAIL/TRAIL death receptor-based cancer therapies.An in-silico study examining the induction of apoptosis by Cryptotanshinone in metastatic melanoma cell lines

P2860

Q28477876-18BFE391-14C4-4E6C-B607-5D1C7B7FC644 Q28544399-22B8C30F-E708-4B37-AEEF-AE3EEFA27554 Q33721556-77138523-1004-49E7-A98B-49B10589CC8C Q33802588-AB7F957E-5D29-4DD2-9A61-ED0839BB2978 Q34184469-A2473315-CD96-4A9D-BAED-AF5636574D66 Q34354511-B45061C2-ECA7-4023-B0A8-CCE3EDEDE29F Q34973290-2DA5A757-B74A-40D9-B8A2-C7BA8AB52910 Q34980645-C3CB5C45-7872-45B9-A00F-84DD7C8393A7 Q35501202-92A7F391-5E55-49C9-99D6-B292F253A56A Q35551640-93076AB4-55D6-405E-8AE8-C58F9B6610B6 Q35830233-3878F0F5-C749-4CF7-8013-74FDCEE812F0 Q36180733-F3E3FB16-4042-496F-B2AA-48B00BD9F882 Q36334890-450F9350-044A-4FA1-A2BC-8A77F7EE0D07 Q36579619-4A283265-FB19-469F-86AE-2DB71747B4A0 Q36608713-70B151B0-DD90-4262-A975-C99F71398284 Q36725089-BF2E4721-10E1-4122-935F-DFC5CFF44964 Q37071019-3AE3CA33-C06D-4614-98B8-B97B84798387 Q37114025-41B8BDFE-84B8-4D0F-AD6B-0459A88FD347 Q37311413-549B57DF-2AAC-44BE-A3A7-B901F5F5C577 Q38098380-71968CDB-615A-44DB-B04C-F7E4E82A0975 Q38112122-50930D08-38FC-42E7-82D9-E88EE24862DF Q38244150-92768780-382F-4F44-8E7A-76E04A022E81 Q38773206-BA2B8D5B-2715-422D-B3B8-F057CD074692 Q38902765-55F26E11-7490-487B-9743-D524700998F8 Q39036440-C0044209-337F-4E3B-9B50-6B1F796135EC Q39072507-CBDFEDA0-3C3A-4DF9-87BA-7CC48286D22B Q39276781-CA88340E-977E-4781-B472-0A8487D9A58B Q39316852-2BB32DD7-04ED-452E-A7A2-C927A5014AA1 Q39514532-7C087B8F-04AD-4BB3-9D65-E1F777EE33D8 Q39863924-0F90F8FE-54B6-4037-97A3-86105F3E225F Q42314590-91C0C048-F9B7-4207-B039-86A4E0621E4C Q42373863-4D052AC6-ED05-456B-8DA8-CAAD3DC43D0C Q51760860-A775826E-F581-469E-96A4-9443BB214CBF Q53278766-472DEAB2-FB5C-464E-AA66-3C9EB2DF3ECE Q53701901-DF1270D2-5520-4002-B46E-E20F92458ECD Q58695175-2A912912-BA54-4695-9989-FDAFC21F51EA

P2860

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

http://www.wikidata.org/entity/Q33564264

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

@ast

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

@en

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

@nl

type

label

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

@ast

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

@en

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

@nl

prefLabel

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

@ast

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

@en

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

@nl

P1433

Q33564264-10516CE9-778D-4DED-9DB0-B743AA97718B

P1476

Q33564264-C25CA512-3493-4497-A7C9-B0219761A714

P2093

Q33564264-48302439-204E-47F0-8436-6781BF52399B

Q33564264-D9FEDC1D-0D67-43A3-96DC-BCBEB6629367

Q33564264-DE23CCA6-F2C2-4F40-BA5F-9AF09FF33D4A

Q33564264-F29AF977-6ACE-4C5B-91FA-4E2DC1033B4D

P2860

Q33564264-0EE54310-3C8B-42F9-A94D-8F9FE7BE1AF1

Q33564264-1C26B2E5-8E44-4A50-AC35-A8271A71AB55

Q33564264-287131FE-D1D9-4EDF-BCF8-337B61137017

Q33564264-2E3564CA-A017-415D-9E30-0B42776582CF

Q33564264-3C3B76AF-6B3C-46A9-903B-CB0A2EE42CDF

Q33564264-43A26CF7-77B1-4D18-90D9-4E865BBC58AB

Q33564264-4483B8AB-9DD8-4BE8-91E0-2865204EADE7

Q33564264-487D1570-569E-4536-98A4-AB787E958170

Q33564264-49D22F2A-C180-4E4A-AA51-A7220D07FB6F

Q33564264-4C43D3EE-CFF4-4C5B-AB1B-A21616EA4EEF

P304

Q33564264-8816189E-A191-4DA5-B4F6-E97AD6FD6797

P31

Q33564264-1AB4C33D-6251-4BC1-A079-36164316FC17

P356

Q33564264-53003FD7-1CCB-47A8-BB0D-0A58E47C6D6A

P407

Q33564264-BED7CCCB-732A-4084-AD24-909149077D30

P433

Q33564264-EFDB88EF-2128-4C5B-A42E-193BA2B8EB93

P478

Q33564264-8EB7B9B1-CA3D-402E-A0CE-8F3701120FF3

P577

Q33564264-C4DF98A8-4988-4CDF-8BE9-6CD3DF6CF52F

P5875

Q33564264-D98C79F7-90C4-4C3B-B6DB-347BF1944784

P698

Q33564264-BBA7A5B4-3EA1-4CD3-8231-DEAB794D438C

P932

Q33564264-1FBEE926-E4A3-45B7-AAF0-CB1AB0E88056

P356

JOURNAL.PONE.0010226

P1433

P1476

Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.

@en

P2093

Gen Sheng Wu

http://www.w3.org/2001/XMLSchema#string

Jing Xu

http://www.w3.org/2001/XMLSchema#string

Jun-Ying Zhou

http://www.w3.org/2001/XMLSchema#string

Wei-Zen Wei

http://www.w3.org/2001/XMLSchema#string

P2860

CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation

Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach.

Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells.

c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment.

Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.

Overview of cell death signaling pathways.

P304

e10226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0010226

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43343444

http://www.w3.org/2001/XMLSchema#string

P698

20419107

http://www.w3.org/2001/XMLSchema#string

P932

2856686

http://www.w3.org/2001/XMLSchema#string